| Literature DB >> 33710457 |
Henk-Jan Boersema1,2,3, Tialda Hoekstra4,5, Femke Abma4,5, Sandra Brouwer4,5.
Abstract
Purpose Inability to work fulltime is an important outcome in the assessment of workers applying for a disability benefit. However, limited knowledge is available about the prevalence and degree of the inability to work fulltime, the associations between disease-related and socio-demographic factors with inability to work fulltime and whether the prevalence and the associations differ across disease groups. Methods Anonymized register data on assessments of workers with residual work capacity (n = 30,177, age 48.8 ± 11.0, 53.9% female) applying for a work disability benefit in 2016 were used. Inability to work fulltime was defined as being able to work less than 8 h per day. Results The prevalence of inability to work fulltime was 39.4%, of these 62.5% could work up to 4 h per day. Higher age (OR 1.01, 95% CI 1.01-1.01), female gender (OR 1.45, 95% CI 1.37-1.52), higher education (OR 1.44, 95% CI 1.33-1.55) and multimorbidity (OR 1.06, 95% CI 1.01-1.11) showed higher odds for inability to work fulltime. Highest odds for inability to work fulltime were found for diseases of the blood, neoplasms and diseases of the respiratory system. Within specific disease groups, different associations were identified between disease-related and socio-demographic factors. Conclusion The prevalence and degree of inability to work fulltime in work disability benefit assessments is high. Specific chronic diseases are found to have higher odds for inability to work fulltime, and associated factors differ per disease group.Entities:
Keywords: Chronic disease; Diagnosis; Disability evaluation; Sick leave; Work
Mesh:
Year: 2021 PMID: 33710457 PMCID: PMC8558289 DOI: 10.1007/s10926-021-09966-7
Source DB: PubMed Journal: J Occup Rehabil ISSN: 1053-0487
Characteristics of the applicants, and differences between applicants with a normal ability and an inability to work fulltime
| Total group | Ability to work fulltime | Inability to work fulltime (n = 11,893) | p-value | |
|---|---|---|---|---|
| Age (years) (mean ± sd) | 48.8 ± 11.0 | 48.5 ± 11.1 | 49.3 ± 10.9 | < .001 |
| Female gender | 16,258 (53.9%) | 9337 (51.1%) | 6921 (58.2%) | < .001 |
| Education level | < .001 | |||
| Low | 15,855 (52.5%) | 10,407 (56.9%) | 5448 (45.8%) | |
| Middle | 9959 (33.0%) | 5648 (30.9%) | 4311 (36.2%) | |
| High | 4363 (14.5%) | 2229 (12.2%) | 2134 (17.9%) | |
| Multimorbidity | 15,893 (52.7%) | 9415 (51.5%) | 6478 (54.5%) | < .001 |
| Disease group | ||||
| No disease | 13 (0.0%) | 13 (0.1%) | – | .004 |
| Infectious and parasitic diseases | 142 (0.5%) | 55 (0.3%) | 87 (0.7%) | < .001 |
| Neoplasms | 1908 (6.4%) | 580 (3.2%) | 1328 (11.2%) | < .001 |
| Diseases of the blood and blood-forming organs | 307 (1.0%) | 78 (0.4%) | 229 (1.9%) | < .001 |
| Endocrine, nutritional and metabolic disorders | 490 (1.6%) | 272 (1.5%) | 218 (1.8%) | .020 |
| Mental and behavioural disorders | 8902 (29.5%) | 5223 (28.6%) | 3679 (30.9%) | < .001 |
| Diseases of the nervous system | 1570 (5.2%) | 615 (3.4%) | 955 (8.0%) | < .001 |
| Diseases of the eye and adnexa | 281 (0.9%) | 182 (1.0%) | 99 (0.8%) | .150 |
| Diseases of the ear and mastoid process | 261 (0.9%) | 154 (0.8%) | 107 (0.9%) | .599 |
| Diseases of the circulatory system | 2345 (7.8%) | 912 (5.0%) | 1433 (12.0%) | < .001 |
| Diseases of the respiratory system | 790 (2.6%) | 262 (1.4%) | 528 (4.4%) | < .001 |
| Diseases of the digestive system | 462 (1.5%) | 182 (1.0%) | 280 (2.4%) | < .001 |
| Diseases of the skin and subcutaneous tissue | 134 (0.4%) | 101 (0.6%) | 33 (0.3%) | < .001 |
| Diseases of the musculoskeletal system and connective tissue | 8612 (28.5%) | 6854 (37.5%) | 1758 (14.8%) | < .001 |
| Diseases of the genitourinary system | 275 (0.9%) | 95 (0.5%) | 180 (1.5%) | < .001 |
| Pregnancy, childbirth and the puerperium | 127 (0.4%) | 96 (0.5%) | 31 (0.3%) | .001 |
| Conditions originating in the perinatal period | – | – | – | |
| Congenital malformations, deformations and chromosomal abnormalities | 137 (0.5%) | 67 (0.4%) | 70 (0.6%) | .005 |
| Symptoms, signs and abnormal clinical and laboratory findings | 1385 (4.6%) | 1056 (5.8%) | 329 (2.8%) | < .001 |
| Injury, poisoning and certain other consequences of external causes | 2010 (6.7) | 1473 (8.1%) | 537 (4.5%) | < .001 |
| External causes of morbidity and mortality | – | – | – | |
| Factors influencing health status | 26 (0.1%) | 14 (0.1%) | 12 (0.1%) | .481 |
| Degree of (in)ability to work fulltime | < .001 | |||
| > 8 h per day | 15,370 (50.9%) | 15,370 (84.1%) | – | |
| ≤ 8 h per day | 2914 (9.7%) | 2914 (15.9%) | – | |
| ≤ 6 h per day | 2494 (8.3%) | – | 2494 (21.0%) | |
| ≤ 4 h per day | 7438 (24.6%) | – | 7438 (62.5%) | |
| ≤ 2 h per day | 1961 (6.5%) | – | 1961 (16.5%) |
Associations of socio-demographic and disease related variables with the inability to work fulltime (univariable and multivariable logistic regression analyses) (n = 30,138)
| Univariable analyses | Multivariable analyses | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Age (years) | 1.01 | 1.01–1.01 | < .001 | 1.01 | 1.01–1.01 | < .001 |
| Female gender | 1.33 | 1.27–1.40 | < .001 | 1.45 | 1.37–1.52 | < .001 |
| Education level | ||||||
| Low (ref) | – | – | – | – | ||
| Middle | 1.46 | 1.39–1.54 | < .001 | 1.33 | 1.25–1.40 | < .001 |
| High | 1.83 | 1.71–1.96 | < .001 | 1.44 | 1.33–1.55 | < .001 |
| Multimorbidity | 1.13 | 1.08–1.18 | < .001 | 1.06 | 1.01–1.11 | 0.031 |
| Disease group | ||||||
| Infectious and parasitic diseases | 6.16 | 4.37–8.66 | < .001 | 6.10 | 4.32–8.61 | < .001 |
| Neoplasms | 8.28 | 7.40–9.26 | < .001 | 8.12 | 7.26–9.08 | < .001 |
| Diseases of the blood and blood-forming organs | 11.42 | 8.79–14.85 | < .001 | 10.91 | 8.37–14.21 | < .001 |
| Endocrine, nutritional and metabolic disorders | 3.12 | 2.59–3.76 | < .001 | 3.06 | 2.54–3.70 | < .001 |
| Mental and behavioural disorders | 2.74 | 2.56–2.93 | < .001 | 2.70 | 2.52–2.90 | < .001 |
| Diseases of the nervous system | 6.04 | 5.39–6.77 | < .001 | 5.83 | 5.19–6.54 | < .001 |
| Diseases of the eye and adnexa | 2.12 | 1.65–2.72 | < .001 | 2.01 | 1.56–2.58 | < .001 |
| Diseases of the ear and mastoid process | 2.70 | 2.10–3.48 | < .001 | 2.50 | 1.94–3.23 | < .001 |
| Diseases of the circulatory system | 6.11 | 5.54–6.75 | < .001 | 6.37 | 5.77–7.05 | < .001 |
| Diseases of the respiratory system | 7.84 | 6.70–9.18 | < .001 | 8.11 | 6.92–9.50 | < .001 |
| Diseases of the digestive system | 6.00 | 4.93–7.27 | < .001 | 5.87 | 4.83–7.14 | < .001 |
| Diseases of the skin and subcutaneous tissue | 1.27 | 0.86–1.89 | .235 | 1.30 | 0.87–1.93 | .209 |
| Diseases of the musculoskeletal system and connective tissue (ref) | – | – | – | – | – | – |
| Diseases of the genitourinary system | 7.37 | 5.72–9.51 | < .001 | 7.29 | 5.64–9.41 | < .001 |
| Pregnancy, childbirth and the puerperium | 1.26 | 0.84–1.89 | .273 | 1.09 | 0.72–1.65 | .674 |
| Congenital malformations, deformations and chromosomal abnormalities | 4.07 | 2.90–5.71 | < .001 | 4.09 | 2.90–5.76 | < .001 |
| Symptoms, signs and abnormal clinical and laboratory findings | 1.55 | 1.37–1.76 | < .001 | 1.20 | 1.05–1.37 | .009 |
| Injury, poisoning and certain other consequences of external causes | 1.42 | 1.27–1.59 | < .001 | 1.46 | 1.30–1.63 | < .001 |
OR odds ratio, CI confidence interval, ref reference group
Population attributable fractions and associations of each disease group with the inability to work fulltime (univariable and multivariable logistic regression analyses, adjusted for gender, age, educational level and multimorbidity) (n = 30,138)
| PAF | Univariable analyses | Multivariable analyses | |||||
|---|---|---|---|---|---|---|---|
| % | OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Infectious and parasitic diseases | 0.26 | 2.44 | 1.74–3.43 | < .001 | 2.40 | 1.70–3.37 | < .001 |
| Neoplasms | 5.17 | 3.53 | 3.19–3.91 | < .001 | 3.18 | 2.87–3.53 | < .001 |
| Diseases of the blood and blood-forming organs | 0.92 | 4.58 | 3.54–5.93 | < .001 | 4.35 | 3.36–5.65 | < .001 |
| Endocrine, nutritional and metabolic disorders | 0.21 | 1.24 | 1.03–1.48 | .021 | 1.20 | 1.00–1.44 | .051 |
| Mental and behavioural disorders | 2.03 | 1.12 | 1.07–1.18 | < .001 | 1.13 | 1.07–1.19 | < .001 |
| Diseases of the nervous system | 2.98 | 2.51 | 2.26–2.78 | < .001 | 2.42 | 2.18–2.69 | < .001 |
| Diseases of the eye and adnexa | − 0.10 | 0.84 | 0.65–1.07 | .150 | 0.77 | 0.60–0.98 | .037 |
| Diseases of the ear and mastoid process | 0.03 | 1.07 | 0.83–1.37 | .599 | 0.95 | 0.74–1.22 | .705 |
| Diseases of the circulatory system | 4.64 | 2.61 | 2.39–2.85 | < .001 | 2.75 | 2.52–3.01 | < .001 |
| Diseases of the respiratory system | 1.87 | 3.20 | 2.75–3.71 | < .001 | 3.34 | 2.87–3.89 | < .001 |
| Diseases of the digestive system | 0.84 | 2.40 | 1.99–2.89 | < .001 | 2.83 | 1.97–2.88 | < .001 |
| Diseases of the skin and subcutaneous tissue | − 0.17 | 0.50 | 0.34–0.74 | .001 | 0.52 | 0.35–0.77 | .001 |
| Diseases of the musculoskeletal system and connective tissue | − 19.29 | 0.29 | 0.27–0.31 | < .001 | 0.29 | 0.27–0.30 | < .001 |
| Diseases of the genitourinary system | 0.61 | 2.94 | 2.29–3.78 | < .001 | 2.87 | 2.23–3.69 | < .001 |
| Pregnancy, childbirth and the puerperium | − 0.16 | 0.50 | 0.33–0.74 | .001 | 0.46 | 0.31–0.69 | < .001 |
| Congenital malformations, deformations and chromosomal abnormalities | 0.14 | 1.61 | 1.15–2.25 | .005 | 1.64 | 1.17–2.30 | .004 |
| Symptoms, signs and abnormal clinical and laboratory findings | − 1.91 | 0.60 | 0.53–0.67 | < .001 | 0.60 | 0.53–0.67 | < .001 |
| Injury, poisoning and certain other consequences of external causes | − 2.30 | 0.54 | 0.49–0.60 | < .001 | 0.56 | 0.50–0.62 | < .001 |
PAF population attributable fraction, OR odds ratio, CI confidence interval
Associations of gender, age, educational level and multimorbidity with the inability to work fulltime stratified for each disease group (multivariable logistic regression analyses, n = 30,138)
| Gender | Age | Educational level | Multimorbidity | ||
|---|---|---|---|---|---|
| Middle | High | ||||
| Infectious and parasitic diseases | 1.44 (0.70–2.95) | 1.00 (0.96–1.03) | 0.70 (0.33–1.51) | 0.61 (0.23–1.59) | 0.96 (0.48–1.93) |
| Neoplasms | 1.31 (1.07–1.61)* | 1.02 (1.01–1.03)** | 1.05 (0.84–1.31) | 1.25 (0.96–1.64) | 0.83 (0.68–1.01) |
| Diseases of the blood and blood-forming organs | 1.78 (1.04–3.07)* | 1.02 (1.00–1.05) | 0.62 (0.34–1.13) | 0.79 (0.38–1.64) | 0.56 (0.32–0.98)* |
| Endocrine, nutritional and metabolic disorders | 1.57 (1.08–2.29)* | 1.00 (0.98–1.02) | 1.32 (0.88–1.98) | 1.36 (0.79–2.35) | 0.95 (0.60–1.52) |
| Mental and behavioural disorders | 1.52 (1.39–1.66)** | 1.00 (1.00–1.01)* | 1.05 (0.95–1.16) | 0.92 (0.82–1.03) | 0.95 (0.87–1.04) |
| Diseases of the nervous system | 1.14 (0.91–1.42) | 1.00 (0.99–1.01) | 2.05 (1.63–2.59)** | 2.69 (1.98–3.66)** | 0.64 (0.52–0.79)** |
| Diseases of the eye and adnexa | 2.61 (1.54–4.41)** | 0.98 (0.85–1.00) | 1.37 (0.77–2.42) | 2.43 (1.16–5.08)* | 1.22 (0.71–2.09) |
| Diseases of the ear and mastoid process | 1.21 (0.73–2.00) | 1.01 (0.98–1.04) | 1.59 (0.89–2.83) | 1.02 (0.52–1.97) | 1.44 (0.85–2.44) |
| Diseases of the circulatory system | 1.62 (1.34–1.94)** | 1.01 (1.00–1.02) | 1.23 (1.02–1.48)* | 1.38 (1.05–1.82)* | 0.79 (0.67–0.95)* |
| Diseases of the respiratory system | 2.04 (1.49–2.79)** | 1.03 (1.01–1.05)* | 1.32 (0.92–1.90) | 1.82 (0.96–3.43) | 0.64 (0.46–0.91)* |
| Diseases of the digestive system | 1.58 (1.07–2.35)* | 1.01 (0.99–1.02) | 1.17 (0.78–1.77) | 1.72 (0.92–3.21) | 0.69 (0.45–1.04) |
| Diseases of the skin and subcutaneous tissue | 0.81 (0.36–1.82) | 1.00 (0.97–1.04) | 1.28 (0.50–3.32) | 1.58 (0.78–5.27) | 2.88 (1.08–7.70)* |
| Diseases of the musculoskeletal system and connective tissue | 1.55 (1.38–1.73)** | 1.01 (1.01–1.02)** | 1.60 (1.42–1.80)** | 2.90 (2.39–3.52)** | 1.66 (1.49–1.85)** |
| Diseases of the genitourinary system | 0.51 (0.30–0.88)* | 1.03 (1.00–1.06)* | 1.22 (0.68–2.19) | 0.99 (0.47–2.09) | 0.47 (0.26–0.85)* |
| Pregnancy, childbirth and the puerperium | n.a. | 1.05 (0.96–1.14) | 2.25 (0.72–7.00) | 4.11 (1.18–14.33)* | 1.20 (0.51–2.87) |
| Congenital malformations, deformations and chromosomal abnormalities | 1.10 (0.51–2.35) | 1.03 (1.00–1.06) | 1.93 (0.89–4.20) | 1.51 (0.53–4.30) | 1.37 (0.61–3.07) |
| Symptoms, signs and abnormal clinical and laboratory findings | 1.11 (0.86–1.44) | 1.01 (1.00–1.02) | 1.72 (1.30–2.28)** | 1.76 (1.22–2.55)* | 1.37 (1.04–1.81)* |
| Injury, poisoning and certain other consequences of external causes | 1.26 (1.03–1.55)* | 1.01 (1.00–1.02) | 1.96 (1.56–2.56)** | 2.85 (2.13–3.82)** | 1.35 (1.10–1.66)* |
*p < .05, **p < .001
n.a. not applicable, due to empty cell(s), the variable was left out of the multivariable regression analysis, OR odds ratio, CI confidence interval